Back
HFA Premium Access

Ipilimumab, pembrolizumab and nivolumab exerts different cardiac and vascular toxicity through DAMPs fibronectin-EDA, S100/calgranulin, galectine-3 and associated NLRP3 inflammasome-chemokine pathway

Session: Heart Failure ePosters - focus on Comorbidities and special population
Topic: Cardio-Oncology
Speaker: Doctor V. Quagliariello (Naples, IT)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Vincenzo Quagliariello

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
0 follower

35 more presentations in this session

A brazilian perspective about the impact of covid 19 on hospitalizations for venous tromboembolism and pulmonary embolism

Speaker: Mr E. Biscarde (BR)

Access
Abstract
Slides
Like
Thumbnail

Diastolic disfunction in precapillary pulmonary hypertension - looking left to see right

Speaker: Doctor P. Alves da Silva (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Pulmonary hypertension in connective tissue diseases with overt of features of venous/capillaries involvement: clinical implications and prognostic impact of this phenotype.

Speaker: Doctor J. Grade Santos (Almada, PT)

Access
Abstract
Slides
Like
Thumbnail

Risk stratification in pulmonary arterial hypertension: do our patients benefit from a 4-strata model?

Speaker: Doctor J. Grade Santos (Almada, PT)

Access
Abstract
Slides
Like
Thumbnail

Comparison of risk scores calculators in patients newly diagnosed with pulmonary arterial hypertension.

Speaker: Doctor J. Grade Santos (Almada, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart Failure ePosters - focus on Comorbidities and special population

Speakers: Doctor V. Quagliariello, Mr E. Biscarde, Doctor P. Alves da Silva, Doctor J. Grade Santos, Doctor J. Grade Santos...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources